Advertising Survey

We would like your input on how advertising is currently used in the site.

Please take this short survey to help us out.

Hide this message

Thoracic Aortic Aneurysms

This PatientPlus article is written for healthcare professionals so the language may be more technical than the condition leaflets. You may find the abbreviations list helpful.

Definitions1,2

An aneurysm is a permanent and irreversible dilatation of a blood vessel by ≥ 50% of its normal expected diameter. Aortic aneurysms are classified as abdominal (the majority) or thoracic. The normal size of the mid-descending thoracic aorta is 26-28 mm. A 'true aneurysm' involves dilatation of all 3 layers of the arterial wall.

Thoracic Aortic Aneurysms (TAA) may affect various parts of the thoracic aorta:

  • Ascending aorta - between aortic annulus and innominate artery (these may cause aortic valve regurgitation if they are proximal enough).
  • Aortic arch.
  • Descending aorta - from the left subclavian artery distally.
  • Thoraco-abdominal aorta - distal thoracic aorta and abdominal aorta.

Epidemiology

  • The incidence is probably about 5-10 per 100,0000.1
  • Prevalence may be at least 3-4 % of those > 65 years, and is probably increasing.2,3

Aetiology

Pathogenesis3

The pathogenesis of TAA probably involves inflammation, proteolysis and reduced survival of smooth muscle cells in the aortic wall. There is probably an imbalance of proteolytic enzymes vs. their inhibitors. Once the aorta reaches a critical diameter (about 6 cm), it loses all distensibility, so that a rise in blood pressure to around 200 mmHg (as can occur physiologically during stress or exertion) can exceed the arterial wall strength and may trigger dissection or rupture.

Causes2,4

Risk factors1,2

Presentation2,3

Most TAAs are asymptomatic (about 95%). They may only be diagnosed incidentally, or if complicated by dissection, rupture, or other complications. Possible presentations are:

  • Pain - located in the chest, neck, upper back, mid-back or epigastrium - the site may relate to which section of aorta is involved.
    • Acute or increasing pain suggests expansion, with the risk of impending rupture or dissection
    • Acute aortic dissection presents with sudden onset, very severe, tearing or sharp pain which is maximal at the time of onset (in contrast to the more dull, crescendo pain of myocardial infarction)3
  • Aortic regurgitation - if a proximal TAA involves the aortic valve.
  • Systemic symptoms, e.g. fever - if infective cause.
  • Thrombo-embolic presentations:
  • Symptoms due to compression of local structures:

Acute aortic dissection

May present with:

  • Severe, sharp pain in the chest, neck or back (as above). The pain may migrate as the dissection progresses.
  • Ischaemia in the territory of any affected artery, e.g. myocardial infarction, neurological features, visceral or limb ischaemia.
  • Unequal upper limb pulses.
  • The dissection may progress to rupture (see below).

Ruptured TAA

May present with:

  • Acute pain - in the chest, neck or back.
  • Collapse, shock or sudden death.
  • If the aneurysm erodes into a nearby structure, there may be:
    • Haematemesis (aorto-oesophageal fistula)
    • Haemoptysis (aorto-bronchial fistula)
    • Haemothorax
    • Cardiac tamponade (ruptures into the pericardium)
    • An acute left to right shunt (aortopulmonary artery fistula)12

Differential diagnosis

This is wide, and TAAs are easily missed or mis-diagnosed. Differential diagnoses include other causes of chest pain, thoracic back pain, arterial ischaemia or collapse.

With acute chest pain, myocardial infarction3 and pulmonary embolus13 are important to differentiate, as these require thrombolysis or anticoagulation, which is contra-indicated for TAA.

Investigations2

Urgent scenario

For an acutely ill patient with suspected thoracic aortic rupture or dissection, the most relevant investigations are:

  • Blood tests - full blood count, clotting screen, renal & liver function and cross-match.
  • ECG.
  • CT scan.

Non-acute scenario

Investigations aim to evaluate the detailed anatomy of the aneurysm, any treatable causes and the patient's fitness for surgery:

  • Blood tests:
    • Full blood count, clotting screen, renal function
    • ESR and/or CRP if inflammatory cause suspected
    • Liver function tests and amylase, if embolisation or dissection suspected
    • Investigate for suspected cause if relevant, e.g. syphilis or HIV serology, connective tissue disease
  • ECG.
  • Lung function tests.
  • Ultrasound:
    • Transthoracic echo shows aortic valve and aortic root
    • Transoesophageal echo shows from the aortic valve to the proximal descending aorta
    • Abdominal ultrasound - to look for associated abdominal aneurysms
  • Scans:
    • CT with contrast is the most widely used diagnostic tool. This defines the precise anatomy and can show the aneurysm, dissection, thrombus or haematoma. Detailed views are needed for endovascular repair planning
    • CT angiography is possible and non-invasive, though the contrast material is nephrotoxic
    • Magnetic resonance imaging (MRI) also shows the anatomy well; the advantage is that MRI angiography is not nephrotoxic
  • Coronary angiography may be appropriate when assessing fitness for surgery, or the possible need for CABAG in addition to aortic surgery.

Management

See also the separate articles Ruptured Aortic Aneurysm, Aortic Dissection linked at top of article.

Who needs surgery?2,3

  1. Immediate/urgent surgery is needed for:
    • Ruptured TAA
    • Some types of aortic dissection
    • Acute symptoms (because these suggest expansion and impending rupture/dissection)
  2. Symptomatic TAAs merit surgery regardless of their size (because there is a higher risk that they will rupture or dissect).
  3. Asymptomatic TAAs are assessed to evaluate the relative risks/benefits of surgery. The risk of rupture depends on:
    • Aneurysm diameter. This is the most important factor predicting rupture. Generally, aneurysms of diameter >5.5 cm (ascending aorta) or >6.5 cm (descending aorta) merit repair
    • Using body surface area as well as aneurysm diameter gives a more accurate risk profile
    • Patients with Marfan's syndrome or a strong family history of TAA merit surgery earlier (at a smaller aneurysm diameter)
    • The rate of expansion is also important

Medical management2

  • Regular monitoring of the aneurysm, e.g. by CT or MRI scans every 6 months.
  • Rigorous blood pressure control.
  • Smoking cessation.
  • Treat underlying cause where feasible, e.g. infection.
  • Treat other cardiovascular risk factors, e.g. hyperlipidaemia.

Driving

There are DVLA restrictions for aneurysms above a certain size, and requirements for notification.14

Surgical repair2

  • This involves thoracotomy to replace the diseased aorta with a Dacron graft.
  • Replacement of the aortic root ± the aortic valve may also be necessary.
  • There are significant perioperative mortality and complication rates (see Prognosis section).

Endovascular repair1

Endovascular repair is also known as 'endovascular stenting', EVAR or TEVAR (the latter for thoracic endovascular repair). It is a minimally invasive technique which is relatively new. It delivers a stent via a remote vessel.

  • Reports from non-randomised studies suggest that endovascular repair may improve early outcomes, with reduced mortality and paraplegia rates.
  • However, TEVAR can have additional complications, i.e. endoleaks, stent fractures, stent graft migration, iliac artery rupture, retrograde dissection, and aorto-oesophageal fistula. These may require re-intervention.
  • Patients receiving stents require frequent follow-up with CT scans.

Prognosis1,2

Natural history:

  • The size of the TAA is the major factor predicting rupture (as above).
  • The natural course is for the aneurysm to slowly increase in size.
  • The five-year mortality rate of TAAs >6 cm is 38-64%.
  • Rupture is the most common cause of death in patients not receiving surgery.
  • When rupture occurs, patients mostly die within six hours. Although about half arrive alive at the hospital, the overall mortality from ruptured TAAs is up to 97%.

With elective surgical repair:

  • Perioperative 30-day mortality is 4.8% with open surgery.
  • Possible complications particular to aortic repair are:
    • Paraplegia due to spinal cord ischaemia - with descending aorta repairs
    • Stroke
    • Renal failure
  • A more detailed review of outcomes after surgery is available.2

Prevention and screening

  • For athletes - one expert advises routine screening of all athletes involved in weight lifting or heavy athletics.3
  • For patients with Marfan's syndrome or Ehlers-Danlos syndrome - lifelong beta-blockers, moderate restriction of physical activity and regular imaging of the aorta.4
  • For patients with a biscuspid aortic valve, assessment of the ascending aorta may be advisable.15


Document references

  1. Abraha I, Romagnoli C, Montedori A, et al; Thoracic stent graft versus surgery for thoracic aneurysm. Cochrane Database Syst Rev. 2009 Jan 21;(1):CD006796. [abstract]
  2. Tseng E. Thoracic aortic aneurysm. emedicine, updated June 2008.
  3. Elefteriades JA; Thoracic aortic aneurysm: reading the enemy's playbook. Yale J Biol Med. 2008 Dec;81(4):175-86. [abstract]
  4. European Society of Cardiology; Diagnosis and management of aortic dissection. Recommendations of the Task Force on Aortic Dissection,; European Heart Journal (2001) 22, 1642-1681 [full text]
  5. OMIM. Aortic Aneurysm Familial Thoracic 1
  6. OMIM. Aortic Aneurysm Familial Thoracic 2
  7. OMIM. Loeys-Dietz syndrome type 1A.
  8. Kan CD, Lee HL, Yang YJ; Outcome after endovascular stent graft treatment for mycotic aortic aneurysm: a systematic review. J Vasc Surg. 2007 Nov;46(5):906-12. Epub 2007 Oct 1. [abstract]
  9. Tilson MD 3rd, Withers L; Arterial aneurysms in HIV patients: molecular mimicry versus direct infection? Ann N Y Acad Sci. 2006 Nov;1085:387-91. [abstract]
  10. Evans JM, O'Fallon WM, Hunder GG; Increased incidence of aortic aneurysm and dissection in giant cell (temporal) arteritis. A population-based study. Ann Intern Med. 1995 Apr 1;122(7):502-7. [abstract]
  11. Lin AE, Lippe B, Rosenfeld RG; Further delineation of aortic dilation, dissection, and rupture in patients with Turner syndrome. Pediatrics. 1998 Jul;102(1):e12. [abstract]
  12. Modi SA, Raza U, Chang S; A case report of thoracic aneurysm with aortopulmonary artery fistula. Eur J Echocardiogr. 2009 Jan 5. [abstract]
  13. Warburton MS, Jackson MA, Norton R, et al; Rare causes of haemoptysis in suspected pulmonary embolism. BMJ. 2004 Sep 4;329(7465):557-8.
  14. At a Glance Guide to the Current Medical Standards of Fitness to Drive, DVLA, Swansea.
  15. Cecconi M, Nistri S, Quarti A, et al; Aortic dilatation in patients with bicuspid aortic valve. J Cardiovasc Med (Hagerstown). 2006 Jan;7(1):11-20. [abstract]

Internet and further reading

  • Walsh SR, Tang TY, Sadat U, et al; Endovascular stenting versus open surgery for thoracic aortic disease: systematic review and meta-analysis of perioperative results. J Vasc Surg. 2008 May;47(5):1094-1098. Epub 2008 Feb 1. [abstract]
  • Cooper DG, Walsh SR, Sadat U, et al; Treating the thoracic aorta in Marfan syndrome: surgery or TEVAR? J Endovasc Ther. 2009 Feb;16(1):60-70. [abstract]

Acknowledgements

EMIS is grateful to Dr N Hartree for writing this article. The final copy has passed scrutiny by the independent Mentor GP reviewing team. ©EMIS 2009.
Document ID: 1814
Document Version: 23
Document Reference: bgp24885
Last Updated: 28 Apr 2009
Provide feedback